555 Twin Dolphin Drive, Suite 360
About PaxVax, Inc.
PaxVax is a leading independent vaccine company devoted to developing and commercializing specialty vaccines that protect against existing and emerging infectious diseases.
48 articles with PaxVax, Inc.
PaxVax, Inc. Announces Positive Interim Results For Phase 3 Cholera Challenge Study; Clinical Trial Program To Proceed As Planned
PaxVax, Inc. Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine
San Diego's PaxVax, Inc. Developing Oral Tablet Vaccine, Looks to Raise More Cash With Support of Seattle’s Ignition Capital